Stocks and Investing Stocks and Investing
Thu, December 9, 2021
[ 12:00 AM ] - WOPRAI
John Rodis Upgraded (CADE) to Strong Buy and Held Target at $35 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Courtney Yakavonis Maintained (CAT) at Sell with Decreased Target to $164 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Paul Trussell Maintained (CASY) at Strong Buy with Decreased Target to $256 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
John Pitzer Maintained (AVGO) at Buy with Increased Target to $62 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Philip Cusick Downgraded (ATUS) to Hold and Held Target at $20 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Kash Rangan Maintained (BASE) at Hold with Decreased Target to $42 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Rick Nelson Maintained (BOOT) at Buy with Increased Target to $138 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Mohit Bansal Initiated (BMY) at Hold and Held Target at $58 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Mike Matson Downgraded (ZBH) to Strong Buy and Decreased Target to $158 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Mohit Bansal Initiated (ABBV) at Buy and Held Target at $165 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Jason Butler Maintained (ACAD) at Buy with Increased Target to $39 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Jay Olson Maintained (ACAD) at Hold with Increased Target to $23 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Courtney Yakavonis Maintained (AGCO) at Buy with Increased Target to $157 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Kristen Owen Initiated (BHIL) at Buy and Held Target at $315 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Mohit Bansal Initiated (BIIB) at Hold and Held Target at $250 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Mark Strouse Upgraded (BEPC) to Buy and Held Target at $52 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Mark Strouse Upgraded (BEP) to Buy and Held Target at $46 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Dara Mohsenian Maintained (BF) at Sell with Increased Target to $66 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Ami Fadia Initiated (BCYC) at Strong Buy and Held Target at $85 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Josh Silverstein Downgraded (APD) to Hold and Held Target at $331 on, Dec 9th, 2021
[ 12:00 AM ] - WOPRAI
Jason Bazinet Initiated (APP) at Strong Buy and Held Target at $112 on, Dec 9th, 2021
Wed, December 8, 2021
[ 12:00 AM ] - WOPRAI
Derek Archila Initiated (ARGX) at Buy and Held Target at $390 on, Dec 8th, 2021
[ 12:00 AM ] - WOPRAI
Derek Archila Initiated (APLS) at Buy and Held Target at $84 on, Dec 8th, 2021
[ 12:00 AM ] - WOPRAI
Tyler Radke Initiated (AMPL) at Strong Buy and Held Target at $80 on, Dec 8th, 2021
[ 12:00 AM ] - WOPRAI
Craig Ellis Maintained (AOSL) at Strong Buy with Increased Target to $67 on, Dec 8th, 2021
[ 12:00 AM ] - WOPRAI
Jeanine Wai Maintained (APA) at Hold with Decreased Target to $26 on, Dec 8th, 2021
[ 12:00 AM ] - WOPRAI
William Quirk Downgraded (BDX) to Hold and Decreased Target to $260 on, Dec 8th, 2021
[ 12:00 AM ] - WOPRAI
Lauren Lieberman Maintained (BF) at Hold with Decreased Target to $72 on, Dec 8th, 2021
[ 12:00 AM ] - WOPRAI
Koji Ikeda Initiated (BIGC) at Strong Buy and Held Target at $66 on, Dec 8th, 2021
[ 12:00 AM ] - WOPRAI
Salveen Richter Maintained (ACAD) at Hold with Increased Target to $28 on, Dec 8th, 2021

Salveen Richter Maintained (ACAD) at Hold with Increased Target to $28 on, Dec 8th, 2021


Published on 2024-10-27 18:55:00 - WOPRAI, Salveen Richter
  Print publication without navigation


Salveen Richter of Goldman Sachs, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $25 to $28 on, Dec 8th, 2021.

Salveen has made no other calls on ACAD in the last 4 months.



There are 6 other peers that have a rating on ACAD. Out of the 6 peers that are also analyzing ACAD, 4 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Jay Olson of "Oppenheimer" Maintained at Hold with Increased Target to $23 on, Tuesday, December 7th, 2021
  • Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $24 on, Tuesday, December 7th, 2021
  • Neena Bitritto-Garg of "Citigroup" Maintained at Hold with Increased Target to $28 on, Tuesday, December 7th, 2021
  • Vamil Divan of "Mizuho" Maintained at Hold with Increased Target to $26 on, Tuesday, December 7th, 2021


These are the ratings of the 2 analyists that currently disagree with Salveen

  • Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $39 on, Tuesday, December 7th, 2021
  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $23 on, Monday, November 1st, 2021
Contributing Sources